147 related articles for article (PubMed ID: 8733827)
1. High prevalence of antibodies to glutamic acid decarboxylase in comparison to islet cell antibodies in patients with long-standing insulin-dependent diabetes mellitus.
Imagawa A; Itoh N; Hanafusa T; Katsura H; Yamaguchi A; Takeda A; Iwahashi H; Nakajima H; Miyagawa J; Namba M; Kuwajima M; Matsuzawa Y
Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):43-52. PubMed ID: 8733827
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies.
Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Yamaguchi Y; Akazawa S; Nagataki S
J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of non-insulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase.
Abiru N; Takino H; Yano M; Kawasaki E; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S
J Autoimmun; 1996 Oct; 9(5):683-8. PubMed ID: 8933285
[TBL] [Abstract][Full Text] [Related]
4. [Islet beta cell function in latent autoimmune diabetes in adults with islet cell antibodies].
Yang L; Zhou ZG; Huang G; Yan X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):309-14. PubMed ID: 16136967
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM).
Yano M; Moriuchi R; Kawasaki E; Watanabe M; Saito K; Takino H; Akazawa S; Miyamoto T; Nagataki S
J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039
[TBL] [Abstract][Full Text] [Related]
6. Combined analysis of long-term anti-beta-cell humoral reactivity in type 1 diabetes with and without thyroid disease.
Maugendre D; Sonnet E; Derrien C; Le Golff MC; Grais MC; Allannic H; Delamaire M
Diabetes Metab; 1999 Mar; 25(1):28-33. PubMed ID: 10335421
[TBL] [Abstract][Full Text] [Related]
7. Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.
Jaeger C; Allendörfer J; Hatziagelaki E; Dyrberg T; Bergis KH; Federlin K; Bretzel RG
Horm Metab Res; 1997 Oct; 29(10):510-5. PubMed ID: 9405979
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus.
Seissler J; Amann J; Mauch L; Haubruck H; Wolfahrt S; Bieg S; Richter W; Holl R; Heinze E; Northemann W
J Clin Invest; 1993 Sep; 92(3):1394-9. PubMed ID: 8376591
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity at diagnosis of combined beta-cell autoantibodies in insulin-dependent diabetic children. French Registry of IDDM in Children Study Group.
Ongagna JC; Levy-Marchal C
Diabetes Metab; 1997 Apr; 23(2):155-60. PubMed ID: 9137905
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
[TBL] [Abstract][Full Text] [Related]
11. Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice.
De Aizpurua HJ; French MB; Chosich N; Harrison LC
J Autoimmun; 1994 Oct; 7(5):643-53. PubMed ID: 7840856
[TBL] [Abstract][Full Text] [Related]
12. Multiple antibody status in type 1 diabetic patients and subjects at various risk with islet-cell antibodies.
Maugendre D; Chaillous L; Rohmer V; Lecomte P; Marechaud R; Saï P; Marre M; Charbonnel B; Allannic H; Delamaire M
Diabetes Metab; 1997 Sep; 23(4):320-6. PubMed ID: 9342546
[TBL] [Abstract][Full Text] [Related]
13. [Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
[TBL] [Abstract][Full Text] [Related]
14. [Islet cell antibodies].
Hanafusa T
Rinsho Byori; 1995 May; 43(5):460-2. PubMed ID: 7783363
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence of anti-GAD autoantibodies in Tunisian children with type 1 diabetes].
Elkadhi A; Khelifi N; Abid A; Nagati K; Jenhani F; Ben Rayana MC
Tunis Med; 2002 May; 80(5):281-5. PubMed ID: 12534034
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to glutamic acid decarboxylase in at-risk and clinical insulin-dependent diabetic subjects: relationship to age, sex and islet cell antibody status, and temporal profile.
Schmidli RS; DeAizpurua HJ; Harrison LC; Colman PG
J Autoimmun; 1994 Feb; 7(1):55-66. PubMed ID: 8198702
[TBL] [Abstract][Full Text] [Related]
17. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients].
Reinsch B; Zimmy S; Schatz H; Pfohl M
Med Klin (Munich); 2003 Feb; 98(2):67-71. PubMed ID: 12601530
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression.
Velloso LA; Kämpe O; Hallberg A; Christmanson L; Betsholtz C; Karlsson FA
J Clin Invest; 1993 May; 91(5):2084-90. PubMed ID: 8486775
[TBL] [Abstract][Full Text] [Related]
19. Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA dqb1*0602 allele.
Gianani R; Verge CF; Moromisato-Gianani RI; Yu L; Zhang YJ; Pugliese A; Eisenbarth GS
J Autoimmun; 1996 Jun; 9(3):423-5. PubMed ID: 8816981
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of patients with the initial diagnosis of NIDDM with positivity for antibodies to glutamic acid decarboxylase.
Inukai T; Fujiwara Y; Tayama K; Aso Y; Ogino K; Takemura Y
Exp Clin Endocrinol Diabetes; 1997; 105(6):327-30. PubMed ID: 9439927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]